Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease (Q35189661)

7 August 2017

1 reference

title

Prevalence, diagnosis, and pharmacological treatment of mood disorders in HIV disease (English)

1 reference

7 August 2017

1 reference

Dean G Cruess

1

1 reference

7 August 2017

Dwight L Evans

2

1 reference

7 August 2017

Martin J Repetto

3

1 reference

7 August 2017

David Gettes

4

1 reference

7 August 2017

Steven D Douglas

5

1 reference

7 August 2017

John M Petitto

6

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

7 August 2017

Biological Psychiatry

1 reference

7 August 2017

54

1 reference

7 August 2017

3

1 reference

7 August 2017

307-316

1 reference

Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. A controlled study

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Rapid reversal of psychotic depression using mifepristone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Protease inhibitor-induced carbamazepine toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

The undertreatment of pain in ambulatory AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Meta-analysis of the relationship between HIV infection and risk for depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Serotonin syndrome in HIV-infected individuals receiving antiretroviral therapy and fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Secondary mania in patients with HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Antidepressant efficacy in HIV-seropositive outpatients with major depressive disorder: an open trial of nefazodone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Mirtazapine for depression in patients with human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

The effect of changes in depression on health related quality of life (HRQoL) in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Mania in AIDS: Clinical Significance and Theoretical Considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants: focus on venlafaxine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Effects of methylphenidate in HIV-related depression: a comparative trial with desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

The relationship of mood, endocrine, and sexual disorders in human immunodeficiency virus positive (HIV+) women: an exploratory study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Anticonvulsant use in the treatment of manic syndromes in patients with HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Extrapyramidal symptoms due to dopamine-blocking agents in patients with AIDS encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Carbamazepine--indinavir interaction causes antiretroviral therapy failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women: longitudinal analysis from the HIV Epidemiology Research Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

7 January 2021

Manic syndrome in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Pharmacologic treatment of mood disorders in acquired immune deficiency syndrome (AIDS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Progression to AIDS, a clinical AIDS condition and mortality: psychosocial and physiological predictors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Psychopathology in male and female intravenous drug users with and without HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Depressive symptoms decline among persons on HIV protease inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Manic syndrome early and late in the course of HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Changes in depressive symptoms as AIDS develops. The Multicenter AIDS Cohort Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

The effect of divalproex sodium on viral load: a retrospective review of HIV-positive patients with manic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

An assessment of rates of psychiatric morbidity and functioning in HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Secondary mania in patients with HIV infection: are antiretrovirals protective?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Severe adverse life events and depressive symptoms among women with, or at risk for, HIV infection in four cities in the United States of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Depressive and anxiety disorders in women with HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Sleep disturbances in men with asymptomatic human immunodeficiency (HIV) infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Stress and depressive symptoms prospectively predict immune change among HIV-seropositive men. HIV Neurobehavioral Research Center Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Somatic symptoms and HIV infection: relationship to depressive symptoms and indicators of HIV disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

The high prevalence of bipolar II and associated cyclothymic and hyperthymic temperaments in HIV-patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Indinavir concentrations and St John's wort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Prevalence of axis I disorders in an AIDS cohort: a cross-sectional, controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Psychological effects of HAART: a 2-year study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

DHEA treatment for HIV+ patients: effects on mood, androgenic and anabolic parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Stability of mood despite HIV illness progression in a group of homosexual men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Psychopathology in male and female HIV-positive and negative injecting drug users: longitudinal course over 3 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Treatment of HIV-related psychotic disorders with risperidone: a series of 21 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Neurobehavioral functioning in a nonconfounded group of asymptomatic HIV-seropositive homosexual men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Neurokinin(1) receptor antagonists as potential antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Delavirdine: clinical pharmacokinetics and drug interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Mood disorders in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Significant interactions with new antiretrovirals and psychotropic drugs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Effects of dextroamphetamine on depression and fatigue in men with HIV: a double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

A comparative analysis of standard and alternative antidepressants in the treatment of human immunodeficiency virus patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Dextroamphetamine as a treatment for depression and low energy in AIDS patients: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection. II. Standardized clinical assessment of current and lifetime psychopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Self-reported oral dryness and HIV disease in a national sample of patients receiving medical care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

Major depression and medication adherence in elderly patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900318-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(03)00318-4

1 reference

7 August 2017

1 reference